These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 22175900

  • 1. Pulmonary adenocarcinoma with a micropapillary pattern: a clinicopathological, immunophenotypic and molecular analysis.
    Zhang J, Liang Z, Gao J, Luo Y, Liu T.
    Histopathology; 2011 Dec; 59(6):1204-14. PubMed ID: 22175900
    [Abstract] [Full Text] [Related]

  • 2. Stromal micropapillary component as a novel unfavorable prognostic factor of lung adenocarcinoma.
    Ohe M, Yokose T, Sakuma Y, Miyagi Y, Okamoto N, Osanai S, Hasegawa C, Nakayama H, Kameda Y, Yamada K, Isobe T.
    Diagn Pathol; 2012 Jan 06; 7():3. PubMed ID: 22225786
    [Abstract] [Full Text] [Related]

  • 3. [Pulmonary adenocarcinoma with micropapillary pattern: a clinicopathologic and immunohistochemical study].
    Zhang J, Liang ZY, Luo YF, Wan JW, Cao JL, Liu TH.
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct 06; 38(10):651-6. PubMed ID: 20078967
    [Abstract] [Full Text] [Related]

  • 4. Association of c-Met phosphorylation with micropapillary pattern and small cluster invasion in pT1-size lung adenocarcinoma.
    Koga K, Hamasaki M, Kato F, Aoki M, Hayashi H, Iwasaki A, Kataoka H, Nabeshima K.
    Lung Cancer; 2013 Dec 06; 82(3):413-9. PubMed ID: 24094902
    [Abstract] [Full Text] [Related]

  • 5. Micropapillary pattern: a distinct pathological marker to subclassify tumours with a significantly poor prognosis within small peripheral lung adenocarcinoma (</=20 mm) with mixed bronchioloalveolar and invasive subtypes (Noguchi's type C tumours).
    Makimoto Y, Nabeshima K, Iwasaki H, Miyoshi T, Enatsu S, Shiraishi T, Iwasaki A, Shirakusa T, Kikuchi M.
    Histopathology; 2005 Jun 06; 46(6):677-84. PubMed ID: 15910599
    [Abstract] [Full Text] [Related]

  • 6. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma.
    Tsubokawa N, Mimae T, Sasada S, Yoshiya T, Mimura T, Murakami S, Ito H, Miyata Y, Nakayama H, Okada M.
    Eur J Cardiothorac Surg; 2016 Jan 06; 49(1):293-9. PubMed ID: 25762400
    [Abstract] [Full Text] [Related]

  • 7. [Prognostic significance of micropapillary pattern in pulmonary adenocarcinoma].
    Lin DM, Ma Y, Liu XY, Zheng S, Xue LY, Liu XY, Zou SM, Lü N, He ZG, Liu FS.
    Zhonghua Bing Li Xue Za Zhi; 2006 Mar 06; 35(3):151-4. PubMed ID: 16630503
    [Abstract] [Full Text] [Related]

  • 8. Pulmonary adenocarcinomas with micropapillary component significantly correlate with recurrence, but can be well controlled with EGFR tyrosine kinase inhibitors in the early stages.
    Sumiyoshi S, Yoshizawa A, Sonobe M, Kobayashi M, Fujimoto M, Tsuruyama T, Date H, Haga H.
    Lung Cancer; 2013 Jul 06; 81(1):53-9. PubMed ID: 23632273
    [Abstract] [Full Text] [Related]

  • 9. Micropapillary lung adenocarcinoma: EGFR, K-ras, and BRAF mutational profile.
    De Oliveira Duarte Achcar R, Nikiforova MN, Yousem SA.
    Am J Clin Pathol; 2009 May 06; 131(5):694-700. PubMed ID: 19369630
    [Abstract] [Full Text] [Related]

  • 10. Micropapillary lung adenocarcinoma: a distinctive histologic subtype with prognostic significance. Case series.
    Sánchez-Mora N, Presmanes MC, Monroy V, Moreno N, Lara-Martínez JM, Aladro MH, Alvarez-Fernández E.
    Hum Pathol; 2008 Mar 06; 39(3):324-30. PubMed ID: 18261622
    [Abstract] [Full Text] [Related]

  • 11. Correlation of mutation status and survival with predominant histologic subtype according to the new IASLC/ATS/ERS lung adenocarcinoma classification in stage III (N2) patients.
    Russell PA, Barnett SA, Walkiewicz M, Wainer Z, Conron M, Wright GM, Gooi J, Knight S, Wynne R, Liew D, John T.
    J Thorac Oncol; 2013 Apr 06; 8(4):461-8. PubMed ID: 23486266
    [Abstract] [Full Text] [Related]

  • 12. Relevance of EGFR mutation with micropapillary pattern according to the novel IASLC/ATS/ERS lung adenocarcinoma classification and correlation with prognosis in Chinese patients.
    Chao L, Yi-Sheng H, Yu C, Li-Xu Y, Xin-Lan L, Dong-Lan L, Jie C, Yi-Lon W, Hui LY.
    Lung Cancer; 2014 Nov 06; 86(2):164-9. PubMed ID: 25236981
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of micropapillary pattern in lung adenocarcinoma and expression of apoptosis-related markers: caspase-3, bcl-2, and p53.
    Cakir E, Yilmaz A, Demirag F, Oguztuzun S, Sahin S, Yazici UE, Aydin M.
    APMIS; 2011 Sep 06; 119(9):574-580. PubMed ID: 21851414
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early-stage lung adenocarcinomas with a micropapillary pattern, a distinct pathologic marker for a significantly poor prognosis.
    Miyoshi T, Satoh Y, Okumura S, Nakagawa K, Shirakusa T, Tsuchiya E, Ishikawa Y.
    Am J Surg Pathol; 2003 Jan 06; 27(1):101-9. PubMed ID: 12502932
    [Abstract] [Full Text] [Related]

  • 16. Frequency of well-identified oncogenic driver mutations in lung adenocarcinoma of smokers varies with histological subtypes and graduated smoking dose.
    Li H, Pan Y, Li Y, Li C, Wang R, Hu H, Zhang Y, Ye T, Wang L, Shen L, Sun Y, Chen H.
    Lung Cancer; 2013 Jan 06; 79(1):8-13. PubMed ID: 23098378
    [Abstract] [Full Text] [Related]

  • 17. High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases.
    Morita S, Yoshida A, Goto A, Ota S, Tsuta K, Yokozawa K, Asamura H, Nakajima J, Takai D, Mori M, Oka T, Tamaru J, Itoyama S, Furuta K, Fukayama M, Tsuda H.
    Am J Surg Pathol; 2013 Jun 06; 37(6):924-32. PubMed ID: 23629442
    [Abstract] [Full Text] [Related]

  • 18. Validation of the IASLC/ATS/ERS lung adenocarcinoma classification for prognosis and association with EGFR and KRAS gene mutations: analysis of 440 Japanese patients.
    Yoshizawa A, Sumiyoshi S, Sonobe M, Kobayashi M, Fujimoto M, Kawakami F, Tsuruyama T, Travis WD, Date H, Haga H.
    J Thorac Oncol; 2013 Jan 06; 8(1):52-61. PubMed ID: 23242438
    [Abstract] [Full Text] [Related]

  • 19. Gastric micropapillary carcinoma: A distinct subtype with a significantly worse prognosis in TNM stages I and II.
    Eom DW, Kang GH, Han SH, Cheon GJ, Han KH, Oh HS, Kim JH, Jang HJ, Hong SM.
    Am J Surg Pathol; 2011 Jan 06; 35(1):84-91. PubMed ID: 21164291
    [Abstract] [Full Text] [Related]

  • 20. Using whole genome amplification (WGA) of low-volume biopsies to assess the prognostic role of EGFR, KRAS, p53, and CMET mutations in advanced-stage non-small cell lung cancer (NSCLC).
    Lim EH, Zhang SL, Li JL, Yap WS, Howe TC, Tan BP, Lee YS, Wong D, Khoo KL, Seto KY, Tan L, Agasthian T, Koong HN, Tam J, Tan C, Caleb M, Chang A, Ng A, Tan P.
    J Thorac Oncol; 2009 Jan 06; 4(1):12-21. PubMed ID: 19096301
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.